ILF roundtable: Rapid access to new technology and reaching the unreached
24 July 2018 | Amsterdam, the Netherlands (By invitation only)
In line with UNAIDS 90-90-90 targets, by 2020, 90% of all people living with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy (ART), and 90% of all people receiving ART will achieve viral suppression. Diagnostic tests are essential to achieve these targets: they form the basis for accurate diagnosis and management of HIV disease and related opportunistic infections. However, many questions remain regarding the optimal pathways for diagnostic test approval, monitoring schema, and equity in global access.
In conjunction with the 22nd International AIDS Conference (AIDS 2018), the ILF roundtable stimulate multi-stakeholder discussions to address the following questions:
- What can be done to speed the pathways to diagnostic test approval and implementation?
- How do we reach equity in access to state of the art diagnostics?
The main objectives for this discussion were to:
- Review important issues around access to diagnostics
- Provide a multi-stakeholder platform for exchange on challenges and solutions to ensure rapid and equitable access to new diagnostic technologies
- Develop a statement on approaches to expedite access to proven - both analytically and in terms of impact – diagnostic technologies.